As of 2026-04-05, the Relative Valuation of Sana Biotechnology Inc (SANA) is (21.00) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.20 USD, the upside of Sana Biotechnology Inc based on Relative Valuation is -756.2%.
The range of the Relative Valuation is (19.32) - (22.18) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.1x - 24.2x | 24.0x |
| Forward P/E multiples | 21.0x - 26.1x | 21.9x |
| Fair Price | (19.32) - (22.18) | (21.00) |
| Upside | -703.9% - -793.1% | -756.2% |
| Date | P/E |
| 2026-04-02 | -3.50 |
| 2026-04-01 | -3.33 |
| 2026-03-31 | -3.15 |
| 2026-03-30 | -2.93 |
| 2026-03-27 | -3.03 |
| 2026-03-26 | -3.31 |
| 2026-03-25 | -3.39 |
| 2026-03-24 | -3.19 |
| 2026-03-23 | -3.41 |
| 2026-03-20 | -3.40 |
| 2026-03-19 | -3.46 |
| 2026-03-18 | -3.42 |
| 2026-03-17 | -3.52 |
| 2026-03-16 | -3.57 |
| 2026-03-13 | -3.67 |
| 2026-03-12 | -3.38 |
| 2026-03-11 | -3.44 |
| 2026-03-10 | -3.60 |
| 2026-03-09 | -3.64 |
| 2026-03-06 | -3.44 |
| 2026-03-05 | -3.73 |
| 2026-03-04 | -4.18 |
| 2026-03-03 | -4.30 |
| 2026-03-02 | -4.54 |
| 2026-02-27 | -4.60 |
| 2026-02-26 | -4.67 |
| 2026-02-25 | -4.56 |
| 2026-02-24 | -4.62 |
| 2026-02-23 | -4.45 |
| 2026-02-20 | -4.38 |
| 2026-02-19 | -4.52 |
| 2026-02-18 | -4.30 |
| 2026-02-17 | -4.21 |
| 2026-02-13 | -4.21 |
| 2026-02-12 | -4.14 |
| 2026-02-11 | -4.24 |
| 2026-02-10 | -4.22 |
| 2026-02-09 | -4.37 |
| 2026-02-06 | -4.30 |
| 2026-02-05 | -3.88 |
| 2026-02-04 | -4.45 |
| 2026-02-03 | -4.82 |
| 2026-02-02 | -5.02 |
| 2026-01-30 | -4.84 |
| 2026-01-29 | -5.03 |
| 2026-01-28 | -5.19 |
| 2026-01-27 | -5.43 |
| 2026-01-26 | -5.21 |
| 2026-01-23 | -5.28 |
| 2026-01-22 | -5.46 |